Trial intelligence / Profile preview

Methylprednisolone Infiltration in Anserine Bursitis

NCT01205477Phase 2Completed

Sponsor
Universidad Autónoma de Nuevo León
Start
Sep 2009
Primary completion
Jul 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone in Pes anserine bursitis (PAPS), sponsored by Universidad Autónoma de Nuevo León. Started Sep 2009; status: completed.

02

Drugs

methylprednisolone
03

Conditions

Pes anserine bursitis (PAPS)

Beyond the preview

Go deeper on NCT01205477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01205477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call